Eric Angevin

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

Joseph Wolfers, Anne Lozier, Graça Raposo et al. · Nature Medicine · 2001 · 1.6K citations

Ctl Cross-priming, Tumor Immunology, Cancer Immunosurveillance +14

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

Bernard Escudier, Thierry Dorval, Nathalie Chaput et al. · Journal of Translational Medicine · 2005 · 1.2K citations · Full text

Malignant effusions and immunogenic tumour-derived exosomes

Fabrice André, Noël E.C. Schartz, Mojgan Movassagh et al. · The Lancet · 2002 · 934 citations

Exosomes, Pathology, Extracellular Microvesicles +4

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Christophe Massard, Stefan Michiels, Charles Ferté et al. · Cancer Discovery · 2017 · 747 citations

Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells

Fabrice André, Nathalie Chaput, Noël E.C. Schartz et al. · The Journal of Immunology · 2004 · 488 citations

Immunology, Current Immunization Protocols, Immunodominance +20